Mesalazine (Systemic)
Mesalazine (Systemic) was ranked 155th of 1,796 medicines by items in May 2026, with 130,186 items, down 5.4% on a year earlier.
Dispensed in May 2026
Rolling 12 months
Net ingredient cost · May 2026
Figure 1. Mesalazine (Systemic): national items dispensed by month
Source: NHSBSA Prescription Cost Analysis, to May 2026
Use this chart on your site
Free to reuse anywhere, including commercially — on your own site, in a report or in an article. Keep the credit link with it and you are done.
A live chart that updates itself when next month's data lands. The credit line is part of the snippet.
An SVG with the title and credit built in. Vector, so it stays sharp at any size in a slide deck or a print layout, and it opens in Illustrator, Figma, Inkscape or any browser.
Paste this beneath the chart if you are using the image rather than the embed.
Chart licensed under CC BY 4.0 — attribution link to PharmaInsight required. Underlying data © NHSBSA, Open Government Licence v3.0.
At a glance
- Therapeutic class Chronic bowel disorders
- Presentations 15 shown
- Average cost / item £57.73
- Year on year Down 5.4% on a year earlier
Top presentations, May 2026
The individual products dispensed under Mesalazine (Systemic) this month.
| Presentation | BNF code | Items | Net ingredient cost |
|---|---|---|---|
| Octasa 800mg MR gastro-resistant tablets | 0105010B0BIAAAS | 35,406 | £2,184,794 |
| Octasa 400mg MR gastro-resistant tablets | 0105010B0BIABAA | 19,522 | £665,840 |
| Mezavant XL 1200mg tablets | 0105010B0BHAAAR | 11,128 | £810,104 |
| Pentasa 500mg modified-release tablets | 0105010B0BCACAI | 10,688 | £516,669 |
| Pentasa 1g modified-release tablets | 0105010B0BCAGAY | 9,089 | £555,528 |
| Mesalazine 1g suppositories | 0105010B0AAAJAJ | 5,384 | £265,139 |
| Salofalk 3g gastro-resistant modified-release gran sachets | 0105010B0BDAKAZ | 4,758 | £359,234 |
| Pentasa 2g modified-release granules sachets | 0105010B0BCAFAT | 4,665 | £346,404 |
| Asacol 800mg MR gastro-resistant tablets | 0105010B0BBAFAS | 4,008 | £323,851 |
| Octasa 1600mg MR gastro-resistant tablets | 0105010B0BIACBD | 2,888 | £227,659 |
| Salofalk 1.5g gastro-resistant modified-release gran sachets | 0105010B0BDAHAU | 2,719 | £136,327 |
| Pentasa 1g modified-release granules sachets | 0105010B0BCAEAN | 2,603 | £142,517 |
| Pentasa 1g suppositories | 0105010B0BCADAJ | 2,026 | £98,004 |
| Salofalk 1g suppositories | 0105010B0BDAIAJ | 1,948 | £71,950 |
| Salofalk 1g/application foam enema | 0105010B0BDAEAK | 1,594 | £111,840 |
Source: NHSBSA Prescription Cost Analysis · to May 2026 OGL v3.0
Where Mesalazine (Systemic) is dispensed
The regions and dispensing practices with the highest Mesalazine (Systemic) volumes.
Top regions
Top dispensing practices
- Modality Partnership (awc) 2,577
- The Ridings Medical Group 1,455
- Stanmore Medical Group 1,338
- Granta Medical Practices 1,100
- James Street Group Pract 933
- Lancaster Medical Practice 843
Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.
Compare Mesalazine (Systemic) with
Other medicines in the same BNF section, by prescribing volume.
Download this data
The monthly series for Mesalazine (Systemic) is in this page's CSV. For the ranked national series across every medicine, with the method and caveats documented, see the most-prescribed medicines dataset in our open data catalogue.